OBrien Eric's Form 4 filing
GreenLight Biosciences Holdings, PBCGRNA · filed Feb 4, 2022
- Accession no.
- 0001062993-22-002732
- Filed
- Feb 4, 2022
- Trade date
- Feb 2, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $7.00M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OBrien EricCIK 0001908829 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Issued pursuant to the terms of a business combination agreement involving the issuer and GreenLight Biosciences, Inc. in exchange for capital stock previously issued by such company.
Referenced by the price of 1 transaction in Table I.
- F3
Amount consists of 700,000 shares of common stock issued pursuant to a subscription agreement entered into between the Issuer and Fall Line Endurance Fund, LP.
Referenced by the price of 1 transaction in Table I.